GEOVAX LABS, INC.

Profile

Company Names

GEOVAX LABS, INC.

Addresses

1900 LAKE PARK DRIVE, SUITE 380, SMYRNA, GA 30080

1900 LAKE PARK DRIVE, SUITE 380, SMYRNA, 2Q 30080

1256 BRIARCLIFF ROAD N.E., EMTECH BIO SUITE 500, ATLANTA, GA 30306

Phone Numbers

678-384-7220
404-727-0971

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$39,142,744.00

Number of Funding Rounds:

11
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
11
2022-05-25 
$15,000,000.00 
$15,000,000.00 
$0.00 
Equity 
10
2022-01-19 
$10,000,000.00 
$10,000,000.00 
$0.00 
Equity 
9
2021-02-11 
$495,000.00 
$495,000.00 
$0.00 
Equity 
8
2020-09-29 
$1,500,000.00 
$1,500,000.00 
$0.00 
Equity 
7
2020-06-26 
$2,400,000.00 
$2,400,000.00 
$0.00 
Debt 
6
2019-07-24 
$700,000.00 
$700,000.00 
$0.00 
Equity 
5
2019-07-16 
$3,256,534.00 
$3,256,534.00 
$0.00 
Equity 
4
2013-12-11 
$1,650,000.00 
$1,650,000.00 
$0.00 
Equity 
3
2012-03-21 
$2,200,000.00 
$2,200,000.00 
$0.00 
Equity 
2
2011-12-30 
$441,210.00 
$1,500,000.00 
$1,058,790.00 
Equity 
1
2009-09-21 
$1,500,000.00 
$1,500,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
STEVEN 
 
ANTEBI 
DIRECTOR
GEOVAX LABS, INC.
RANDAL 
D. 
CHASE 
DIRECTOR
GEOVAX LABS, INC.
DAVID 
 
DODD 
DIRECTOR
GEOVAX LABS, INC.
DAVID 
A 
DODD 
DIRECTOR
GEOVAX LABS, INC.
DAVID 
A. 
DODD 
EXECUTIVE OFFICER, DIRECTOR
PNP THERAPEUTICS INC   |  GEOVAX LABS, INC.
FARSHAD 
 
GUIRAKHOO 
EXECUTIVE OFFICER
GEOVAX LABS, INC.
DONALD 
 
HILDEBRAND 
DIRECTOR
GEOVAX LABS, INC.
DEAN 
 
KOLLINTZAS 
DIRECTOR
GEOVAX LABS, INC.
DEAN 
G 
KOLLINTZAS 
DIRECTOR
GEOVAX LABS, INC.
DEAN 
G. 
KOLLINTZAS 
DIRECTOR
GEOVAX LABS, INC.
ROBERT 
 
MCNALLY 
EXECUTIVE OFFICER, DIRECTOR
GEOVAX LABS, INC.
ROBERT 
T 
MCNALLY 
EXECUTIVE OFFICER, DIRECTOR
GEOVAX LABS, INC.
ROBERT 
T. 
MCNALLY 
DIRECTOR, EXECUTIVE OFFICER
GEOVAX LABS, INC.
MARK 
J. 
NEWMAN 
EXECUTIVE OFFICER
GEOVAX LABS, INC.
MARK 
 
REYNOLDS 
EXECUTIVE OFFICER
GEOVAX LABS, INC.   |  BEP OMAHA II LLC   |  BEP CO SPRINGS II LLC
MARK 
W 
REYNOLDS 
EXECUTIVE OFFICER
GEOVAX LABS, INC.
MARK 
W. 
REYNOLDS 
EXECUTIVE OFFICER
GEOVAX LABS, INC.
HARRIET 
 
ROBINSON 
EXECUTIVE OFFICER, DIRECTOR
GEOVAX LABS, INC.
HARRIET 
L 
ROBINSON 
EXECUTIVE OFFICER, DIRECTOR
GEOVAX LABS, INC.
HARRIET 
L. 
ROBINSON 
DIRECTOR
GEOVAX LABS, INC.
JOHN 
 
SPENCER 
DIRECTOR
GEOVAX LABS, INC.   |  AIRESOURCE TECHNOLOGIES, LLC   |  ONCETHERE, INC.
JOHN 
N. 
SPENCER 
DIRECTOR
GEOVAX LABS, INC.
JOHN 
N. 
SPENCER, JR. 
DIRECTOR
MRI INTERVENTIONS, INC.   |  GEOVAX LABS, INC.
PETER 
 
TSOLINAS 
DIRECTOR
GEOVAX LABS, INC.   |  PSI GEN 2 FUNDING, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-06-22
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-05-25 
2022-01-20
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-01-19 
2021-02-25
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-02-11 
2020-10-08
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-09-29 
2020-07-06
D
Link
BIOTECHNOLOGY 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
DECLINE TO DISCLOSE 
Debt 
2020-06-26 
2019-11-01
D/A
Link
BIOTECHNOLOGY 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
DECLINE TO DISCLOSE 
Equity 
2019-07-16 
2019-11-01
D/A
Link
BIOTECHNOLOGY 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
DECLINE TO DISCLOSE 
Equity 
2019-07-24 
2019-11-01
D
Link
BIOTECHNOLOGY 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
DECLINE TO DISCLOSE 
Equity 
2019-07-24 
2019-10-31
D
Link
BIOTECHNOLOGY 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
DECLINE TO DISCLOSE 
Equity 
2019-07-16 
2013-12-23
D
Link
BIOTECHNOLOGY 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
DECLINE TO DISCLOSE 
Equity 
2013-12-11 
2012-04-02
D
Link
BIOTECHNOLOGY 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
DECLINE TO DISCLOSE 
Equity 
2012-03-21 
2012-01-13
D
Link
BIOTECHNOLOGY 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
$1 - $1,000,000 
Equity 
2011-12-30 
2009-09-30
D
Link
BIOTECHNOLOGY 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
$1,000,001 - $5,000,000 
Equity 
2009-09-21 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
H.C. WAINWRIGHT + CO., LLC
375
NONE
NONE
MAXIM GROUP LLC
120708
NONE
NONE
MOODY CAPITAL, LLC
15989